Therapeutic vaccination following early antiretroviral therapy elicits highly functional T cell responses against conserved HIV-1 regions
2023 · Scientific Reports · 10 citations
https://doi.org/10.1038/s41598-023-42888-3
J
Jakub Kopycinski
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
45
Papers
1.7K
Citations
24
h-index
33
i10-index
Jakub Kopycinski is an academic researcher from Atara Biotherapeutics (United States). The author has contributed to research in topics: HIV Research and Treatment & Immune Cell Function and Interaction & HIV/AIDS Research and Interventions. The author has an h-index of 24, co-authored 39 publications.
Papers by this author
worksIncoming HIV virion-derived Gag Spacer Peptide 2 (p1) is a target of effective CD8+ T cell antiviral responses
2021 · Cell Reports · 4 citations
https://doi.org/10.1016/j.celrep.2021.109103
A Phase 1b/2, Randomised, Placebo-controlled Study to Evaluate Safety, Tolerability, Efficacy, and Immunogenicity of VTP-200, a Chimpanzee Adenovirus and Modified Vaccinia Ankara-vectored Multigenotype High-risk Human Papillomavirus Vaccine in Women With Low-grade Cervical Lesions
2025 · Clinical Infectious Diseases · 0 citations
https://doi.org/10.1093/cid/ciaf658
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat